Illumina, Inc. (NASDAQ:ILMN) will plough in a $100 million for investment towards a new venture capital firm, Illumina Ventures. The venture capital fund which has been established by Illumina’s former…
Results from two Phase 3 clinical trials evaluating C-EDGE Head-to-Head hepatitis C virus (HCV) drug, Zepatier from Merck & Co., Inc. (NYSE:MRK) seems to be positive. The 50mg/100mg tablets are…
Pfizer Inc. (NYSE:PFE) is on the receiving end and must endure a £10,000 ($14,100) penalty for late submission of documents required by the country’s Competition and Markets Authority (CMA). However,…
Pfizer Inc. (NYSE:PFE) and New Enterprise Associates are some of the backers that are supporting the launch of the second rare-disease venture from biotech builders at Cydan Development. The backers…
Merck & Co., Inc. (NYSE:MRK) has decided to let go its plans of filing what was once seen as a key player in its late-stage pipeline, once-weekly DPP-4 drug omarigliptin.…
Boston Scientific Corporation (NYSE:BSX) is facing criminal investigation over alleged use of counterfeit Transvaginal mesh implants. Federal prosecutors are in the process of convening a grand jury to consider alleged…
It is not the end of the road for Clovis Oncology Inc (NASDAQ:CLVS)’s lung cancer candidate rociletinib, but it means things cannot progress as fast as the company had hoped…
Stryker Corporation (NYSE:SYK) has added SafeWire to its portfolio, continuing a string of acquisitions that have seen the company close multiple buyout deals in the recent months. By acquiring SafeWire,…
Medtronic PLC (NYSE:MDT) is celebrating study findings that showed its insulin pump MiniMed delivered favorable outcomes in a controlled clinical trial that covered a large pool of patients. MiniMed was…
Shaft breakage complaints on all models of its Fetch 2 Aspiration Catheter from Boston Scientific Corporation (NYSE:BSX) have led to the recalling of the product. According to the Food Drug…
